---
title: "Humana Inc Q2 2026: Revenue $40.9B, EPS $5.73— 10-Q Summary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294243495.md"
description: "Humana Inc reported Q2 2026 results with revenue of $40.9B, up 26.2% YoY, and diluted EPS of $5.73, a 27.1% increase. Growth was driven by Medicare membership expansion and higher premiums. Individual Medicare Advantage membership rose 23%, while PDP membership surged 63%. CenterWell segment saw ~32% revenue growth due to primary care and pharmacy expansion. Operational efficiency improved, helping offset Star Ratings headwinds."
datetime: "2026-07-29T18:21:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294243495.md)
  - [en](https://longbridge.com/en/news/294243495.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294243495.md)
---

# Humana Inc Q2 2026: Revenue $40.9B, EPS $5.73— 10-Q Summary

Humana Inc reported second-quarter 2026 results with revenue of $40.9B and diluted EPS of $5.73, reflecting double-digit top-line growth and higher earnings versus the year-ago quarter.

**Financial Highlights**

-   Revenue was $40.9B, compared with $32.4B in the prior-year quarter; YoY change 26.2%.
-   Net income was $694M, compared with $545M in the prior-year quarter; YoY change 27.6%.
-   Diluted EPS was $5.73, compared with $4.51 in the prior-year quarter; YoY change 27.1%.

**Business Highlights**

-   Revenue growth of about 26% year-over-year was driven by Medicare membership expansion and higher per-member Medicare Advantage and PDP premiums.
-   Individual Medicare Advantage membership rose 23% while PDP membership increased 63%, reflecting strong enrollment through AEP/OEP and group recontracting.
-   CenterWell continued momentum with roughly 32% revenue growth, supported by primary care and pharmacy expansion and the MaxHealth acquisition to scale Florida primary care.
-   Operational efficiency improved as value-creation and transformation initiatives helped offset some Star Ratings headwinds, improving operating cost ratios.

Original SEC Filing: HUMANA INC \[ HUM \] - 10-Q - Jul. 29, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [HUM.US](https://longbridge.com/en/quote/HUM.US.md)

## Related News & Research

- [US Insurer Humana Is Exiting More Medicare Advantage Plans in 2027— Here's Who Could Be Affected](https://longbridge.com/en/news/294371234.md)
- [Humana's Strong Quarter Fails To Impress](https://longbridge.com/en/news/294238110.md)
- [Humana Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts](https://longbridge.com/en/news/294168198.md)
- [Humana director John P. Smith files initial beneficial ownership statement](https://longbridge.com/en/news/294247908.md)
- [Humana (HUM) Could Be 91% Overvalued As Medicare Scrutiny Reframes Valuation](https://longbridge.com/en/news/292818516.md)